SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-008004
Filing Date
2017-05-04
Accepted
2017-05-04 16:30:04
Documents
3
Period of Report
2017-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20170504_8k.htm 8-K 17919
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 148778
3 img.jpg GRAPHIC 9304
  Complete submission text file 0001437749-17-008004.txt   181070
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 17814403
SIC: 2836 Biological Products, (No Diagnostic Substances)